Eli Lilly and Company LLY announced that the FDA has granted approval to its IL-13 inhibitor Ebglyss (lebrikizumab) for ...

Navigator Medicines has equipped itself with $100 million in series A funds as the young biotech charts a course for ... Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase ...

Discover Action Bronson’s weight loss approach and how he physically transformed himself within 9 months. From workout regime ...

Skyrizi is approved for forms of arthritis, psoriasis and Crohn's disease in the U.S., while Rinvoq treats arthritis, eczema and ulcerative colitis. - Biopharma Dive "As the first treatment to ...

Around 100 trillion microbes reside in your gut. Cleveland Clinic nutrition experts reveal the indicators for good gut health ...

Children who have hay fever, asthma, eczema, or food allergies are known ... "Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources ...

Many will understand how much of an impact the skin condition eczema can have on daily life. The constant discomfort of dry, itchy and red skin can massively decrease someone’s overall wellbeing ...

Eczema can show up as crusty, flaky patches on your baby's skin, often during their first few months. It’s common and treatable, and many infants outgrow it. Not sure if your baby's itchy ...

Eli Lilly said the Food and Drug Administration approved its treatment for moderate-to-severe eczema that isn't well controlled despite treatment with topical prescription therapies. The treatment ...

Eczema is now a worldwide epidemic. In the UK up to one-fifth of school-age children and one in 12 adults suffer from it. It is itchy, painful and often unsightly, reduces the quality of life and ...

When you have eczema, you may already know that some cosmetics irritate your skin -- but that doesn’t mean you have to give up on makeup. Some products may trigger a flare, but others have ...